First, hypoglycemic episodes during sleep are harder to detect and respond to
Research has confirmed that the peptide lacks the systemic effects of growth hormone, showing no impact on IGF-1 levels, glucose metabolism, or growth-promoting effects in other tissues
History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
Some studies have suggested that rapid improvements in glycemic control with semaglutide may be associated with temporary worsening of diabetic retinopathy in certain patients, particularly those with pre-existing retinopathy
Liver, spleen, and pancreas are often affected
Q: Is it safe for infants or neonates